Promoter hypermethylation of FBXO32 , a novel TGF- β /SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

Jian-Liang Chou,Her Young Su,Lin Yu Chen,Yu Ping Liao,Corinna Hartman-Frey,Yi-Hui Lai,Hui-Wen Yang,Daniel E. Deatherage,Chieh Ti Kuo,Yi-Wen Huang,Pearlly S. Yan,Shu-Huei Hsiao,Chien-Kuo Tai,Huey-Jen L. Lin,Ramana V. Davuluri,Tai-Kuang Chao,Kenneth P. Nephew,Tim H M Huang,Hung Cheng Lai,Michael W.Y. Chan

Promoter hypermethylation of FBXO32 , a novel TGF- β /SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

2010

Promoter hypermethylation of FBXO32 , a novel TGF- β /SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer

Keywords:

FBXO32
Ovarian cancer
DNA methylation
Suppressor
Cancer
Immunology
Cancer research
Azacitidine
Transforming growth factor beta
Biology
Tumor suppressor gene
Methylation
Epigenetics
Cell growth

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations